Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
1997-3-4
|
pubmed:abstractText |
The two major fibrinolytic activators, urokinase-type plasminogen activator (u-PA) and tissue-type plasminogen activator (t-PA) may play role in tumor spread and metastasis. Malign pleural mesothelioma (MPM) is a kind of tumor with predominantly local invasion and low incidence of distant metastasis. In this study, u-PA, t-PA and PA activator-1 (PAI-1) antigen and activity were measured in plasma and pleural fluid samples from patients with MPM, lung cancer and benign effusion. When compared to the control group, in MPM group, plasma u-PA and t-PA antigen levels were higher, but plasma u-PA and t-PA activity were comparable. PAI-1 antigen was also higher in MPM group. These findings were in contrast to the lung cancer group, in which both activity and immunologic measurement of u-PA and t-PA were higher, but PAI-1 antigen was similar as compared to the control group. It is concluded that excess t-PA and u-PA are balanced in complexes with PAI-1 in MPM, whereas the amount of PAI-1 in plasma is insufficient to overcome the elevated t-PA and u-PA, in lung cancer. Based on these findings, it may be suggested that the balanced fibrinolytic system is responsible for the low incidence of distant metastasis in MPM.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0049-3848
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
84
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
121-8
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:8897701-Adult,
pubmed-meshheading:8897701-Female,
pubmed-meshheading:8897701-Fibrinolysis,
pubmed-meshheading:8897701-Humans,
pubmed-meshheading:8897701-Lung Neoplasms,
pubmed-meshheading:8897701-Male,
pubmed-meshheading:8897701-Mesothelioma,
pubmed-meshheading:8897701-Middle Aged,
pubmed-meshheading:8897701-Plasminogen Activator Inhibitor 1,
pubmed-meshheading:8897701-Plasminogen Activators,
pubmed-meshheading:8897701-Pleural Effusion,
pubmed-meshheading:8897701-Pleural Neoplasms,
pubmed-meshheading:8897701-Urokinase-Type Plasminogen Activator
|
pubmed:year |
1996
|
pubmed:articleTitle |
Fibrinolytic system in plasma and pleural fluid in malignant pleural mesothelioma.
|
pubmed:affiliation |
Hacettepe University Medical School, Department of Internal Medicine, Ankara, Turkey.
|
pubmed:publicationType |
Journal Article
|